Skip to main content
FACDX logo

Fidelity Advisor Health Care Fund Class A (FACDX) Fund Overview

Educational signal · not a buy or sell recommendation · How to read this

$66.43 +$1.17 (+1.79%)

Beta 0.85: the stock has moved about 15% less than the S&P 500.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 18, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

Fidelity Advisor Health Care Fund Class A (FACDX) trades at $66.43. Fidelity Advisor Health Care Fund Class A (FACDX) is a non-diversified fund focusing on capital appreciation through investments in healthcare-related companies. Sector: Financials.

Price as of · Last analyzed: Mar 18, 2026
Fidelity Advisor Health Care Fund Class A (FACDX) is a non-diversified fund focusing on capital appreciation through investments in healthcare-related companies. The fund invests primarily in common stocks of both domestic and foreign issuers within the healthcare sector.

Analyst Coverage for FACDX: FACDX does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.

▶ Watch the FACDX film Every key number, told as a short cinematic story — just press play. ~2 min

Fidelity Advisor Health Care Fund Class A (FACDX) Financial Services Profile

IPO Year1996

Fidelity Advisor Health Care Fund Class A (FACDX) seeks capital appreciation by investing at least 80% of its assets in healthcare companies, utilizing fundamental analysis of financial conditions, industry positions, and macroeconomic factors to select domestic and foreign issuers.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 18, 2026

What Is the Investment Thesis for FACDX?

AI-written as of Mar 18, 2026 — figures and tone reflect the data available then, not today's score.

Fidelity Advisor Health Care Fund Class A (FACDX), with a market capitalization of $3.15 billion and a beta of 0.85, presents a targeted investment in the healthcare sector. The fund's strategy of investing at least 80% of its assets in healthcare-related companies offers exposure to a sector driven by long-term demographic trends and technological advancements. Key value drivers include the fund's ability to identify and invest in companies with strong growth prospects and sustainable competitive advantages within the healthcare industry. Upcoming catalysts include potential breakthroughs in medical technology and favorable regulatory developments. Potential risks include regulatory changes, such as drug pricing reforms, and increased competition within the healthcare industry.

Based on FMP financials and quantitative analysis

FACDX Key Highlights

AI-written as of Mar 18, 2026 — figures and tone reflect the data available then, not today's score.

The fund invests at least 80% of its assets in securities of companies principally engaged in the health care or medicine sector.

  • FACDX utilizes fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions, to select investments.
  • The fund invests in both domestic and foreign issuers, providing exposure to the global healthcare market.
  • The fund has a beta of 0.85, indicating lower volatility compared to the broader market.
  • The fund's market capitalization is $3.15 billion.

Who Are FACDX's Competitors?

FACDX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
EAGL Eagle Capital Select Equity ETF $34.68 +1.85% $4.33B —
FACTX Fidelity Advisor Health Care Fund Class M $58.62 +1.79% $3.39B —
FBMPX Fidelity Select Multimedia Portfolio $145.05 +1.21% $2.82B —
FELIX Fidelity Advisor Semiconductors Fund $207.10 +0.89% $6.29B —
FHCCX Fidelity Advisor Health Care Fund Class C $43.32 +1.76% $3.45B —
BLK BlackRock, Inc. $1066.45 +0.64% $165B 51 5-pillar
BX Blackstone Inc. $111.64 -0.09% $136B 68 5-pillar
APOS Apollo Global Management, Inc. $25.59 0.00% $74.8B 56 5-pillar

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are FACDX's Key Strengths?

Focus on a defensive sector (healthcare).

  • Experienced management team at Fidelity.
  • Access to global healthcare markets.
  • Established investment process based on fundamental analysis.

What Are FACDX's Weaknesses?

Non-diversified nature increases sector-specific risk.

  • Performance is highly dependent on the healthcare sector's performance.
  • Subject to regulatory and political risks in the healthcare industry.
  • Management fees can impact overall returns.

What Are the Key Risks for FACDX?

Regulatory changes impacting the healthcare industry (e.g., drug pricing reforms).

  • Increased competition within the healthcare industry.
  • Economic downturn impacting healthcare spending.
  • Market volatility affecting the value of healthcare stocks.
  • Risks associated with investing in foreign healthcare companies.

What Are FACDX's Competitive Advantages?

  • Established brand reputation of Fidelity Investments.
  • Access to Fidelity's extensive research and analytical resources.
  • Experienced portfolio management team with expertise in the healthcare sector.
  • Large asset base providing economies of scale.

What Does FACDX Do?

Fidelity Advisor Health Care Fund Class A (FACDX) is an actively managed, non-diversified fund within the Fidelity Investments family. The fund's primary objective is to achieve capital appreciation by focusing its investments in the healthcare sector. FACDX invests at least 80% of its assets in the securities of companies principally engaged in the design, manufacture, or sale of products or services used for or in connection with healthcare or medicine. This includes companies involved in pharmaceuticals, biotechnology, medical devices, healthcare services, and related fields. The fund invests in both domestic and foreign issuers, providing exposure to the global healthcare market. FACDX employs a fundamental analysis approach, evaluating factors such as an issuer's financial condition, industry position, and prevailing market and economic conditions to make investment decisions. The fund's investment strategy aims to identify companies with strong growth potential and sustainable competitive advantages within the healthcare industry. FACDX offers investors a way to gain targeted exposure to the healthcare sector, which is often considered defensive due to the essential nature of healthcare services and products. The fund's performance is subject to the risks associated with the healthcare industry, including regulatory changes, technological advancements, and demographic trends.

What Products and Services Does FACDX Offer?

  • Invests primarily in common stocks of healthcare companies.
  • Focuses on companies engaged in the design, manufacture, or sale of healthcare products and services.
  • Invests in both domestic and foreign healthcare issuers.
  • Employs fundamental analysis to select investments.
  • Seeks to achieve capital appreciation.
  • Targets companies with strong growth potential and sustainable competitive advantages.

How Does FACDX Make Money?

  • Generates revenue through capital appreciation of its investments in healthcare companies.
  • Charges management fees based on the fund's assets under management (AUM).
  • Utilizes fundamental analysis to identify undervalued or high-growth potential healthcare stocks.
  • Distributes capital gains to shareholders.

What Industry Does FACDX Operate In?

Fidelity Advisor Health Care Fund Class A (FACDX) operates within the asset management industry, specifically targeting the healthcare sector. The healthcare industry is characterized by consistent growth driven by an aging population, technological advancements, and increasing healthcare spending. The competitive landscape includes other healthcare-focused funds such as EAGL, FACTX, FBMPX, FELIX, and FHCCX, each with its own investment strategy and risk profile. FACDX differentiates itself through its fundamental analysis approach and its focus on both domestic and foreign healthcare companies.

Who Are FACDX's Key Customers?

  • Individual investors seeking exposure to the healthcare sector.
  • Institutional investors, including pension funds and endowments.
  • Financial advisors looking for healthcare-focused investment options for their clients.
  • Retirement savers seeking long-term capital appreciation.
Model self-rating on this text: 83% (not a measure of the evidence) Updated: Mar 18, 2026

Research confidence

Low

Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.

  • ● Scoring coverage unknown
  • ● Price is current
  • ● No filing on record
  • ● No analyst coverage
  • ● This is a fund, not an operating company

MoonshotScore History

Recorded daily since 2026-08-23 · 41 snapshots

2026-08-23 44
2026-08-31 44
2026-09-08 44
2026-09-16 44
2026-09-24 44
2026-10-04 44

What changed?

The score has stayed at 44.

Over the same 30 days the stock moved -1.9%.

FACDX Financials

Bull Case vs Bear Case

Bull Case

  • Focus on a defensive sector (healthcare).
  • Experienced management team at Fidelity.
  • Access to global healthcare markets.
  • Established investment process based on fundamental analysis.

Bear Case

  • Non-diversified nature increases sector-specific risk.
  • Performance is highly dependent on the healthcare sector's performance.
  • Subject to regulatory and political risks in the healthcare industry.
  • Management fees can impact overall returns.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026

FACDX Latest News

No recent news available for FACDX.

FACDX Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for FACDX.

Price Targets

Wall Street price target analysis for FACDX.

FACDX MoonshotScore

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for FACDX; grades run from A+ (80-100) to F (below 30).

FACDX Financials Stock FAQ

How does FACDX compare to other healthcare-focused funds?

Fidelity Advisor Health Care Fund Class A (FACDX) competes with other healthcare-focused funds such as EAGL, FACTX, FBMPX, FELIX, and FHCCX. While all these funds invest in the healthcare sector, they may differ in their investment strategies, portfolio composition, and risk profiles.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated

MoonshotScore is not published for this security.

Data Sources & Methodology
Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • The information provided is based on available data and is subject to change.
  • Investment decisions should be made based on individual circumstances and consultation with a financial advisor.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis